Abstract
Patients with chronic diseases such as cardiovascular diseases, chronic respiratory diseases, and neurological diseases have been shown to benefit from treatments such as aromatherapy in addition to medication. Most chronic diseases are caused by chronic inflammation and oxidative stress as well as harmful factors. Eucalyptol (1,8-cineole), a terpenoid oxide isolated from Eucalyptus species, is a promising compound for treating such conditions as it has been shown to have anti-inflammatory and antioxidant effects in various diseases, including respiratory disease, pancreatitis, colon damage, and cardiovascular and neurodegenerative diseases. Eucalyptol suppresses lipopolysaccharide (LPS)-induced proinflammatory cytokine production through the action of NF-κB, TNF-α, IL-1β, and IL-6 and the extracellular signal-regulated kinase (ERK) pathway, and reduces oxidative stress through the regulation of signaling pathways and radical scavenging. The effects of eucalyptol have been studied in several cell and animal models as well as in patients with chronic diseases. Furthermore, eucalyptol can pass the blood–brain barrier and hence can be used as a carrier to deliver drugs to the brain via a microemulsion system. In summary, the various biological activities of eucalyptol such as its anti-inflammatory and antioxidant properties, as well as its physicochemical characteristics, make this compound a potentially important drug for the treatment of chronic diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aparicio S, Alcalde R, Davila MJ, Garcia B, Leal JM (2007) Properties of 1,8-cineole: a thermophysical and theoretical study. J Phys Chem B 111(12):3167–3177. doi:10.1021/jp067405b
Bastos VP, Gomes AS, Lima FJ, Brito TS, Soares PM, Pinho JP, Magalhaes PJ (2011) Inhaled 1,8-cineole reduces inflammatory parameters in airways of ovalbumin-challenged Guinea pigs. Basic Clin Pharmacol Toxicol 108(1):34–39. doi:10.1111/j.1742-7843.2010.00622.x
Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in cardiovascular diseases. J Hypertens 18(6):655–673
Edwards T (2005) Inflammation, pain, and chronic disease: an integrative approach to treatment and prevention. Altern Ther Health Med 11(6), 20–27; quiz 28, 75
Elwood P, Galante J, Pickering J, Palmer S, Bayer A, Ben-Shlomo Y, Gallacher J (2013) Healthy lifestyles reduce the incidence of chronic diseases and dementia: evidence from the Caerphilly cohort study. PLoS ONE 8(12):e81877. doi:10.1371/journal.pone.0081877
Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121(11):2381–2386. doi:10.1002/ijc.23192
Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4–S9. doi:10.1093/gerona/glu057
Greiner JF, Muller J, Zeuner MT, Hauser S, Seidel T, Klenke C, Kaltschmidt C (2013) 1,8-Cineol inhibits nuclear translocation of NF-kappaB p65 and NF-kappaB-dependent transcriptional activity. Biochim Biophys Acta 1833(12):2866–2878. doi:10.1016/j.bbamcr.2013.07.001
Guha M, O’Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Mackman N (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98(5):1429–1439
He X, Wei Z, Zhou E, Chen L, Kou J, Wang J, Yang Z (2015) Baicalein attenuates inflammatory responses by suppressing TLR4 mediated NF-kappaB and MAPK signaling pathways in LPS-induced mastitis in mice. Int Immunopharmacol 28(1):470–476. doi:10.1016/j.intimp.2015.07.012
Juergens UR (2014) Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases. Drug Res (Stuttg), 64(12), 638–646. doi:10.1055/s-0034-1372609
Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H (2003) Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med 97(3):250–256
Jun YS, Kang P, Min SS, Lee JM, Kim HK, Seol GH (2013) Effect of eucalyptus oil inhalation on pain and inflammatory responses after total knee replacement: a randomized clinical trial. Evid Based Complement Alternat Med 2013:502727. doi:10.1155/2013/502727
Kehrl W, Sonnemann U, Dethlefsen U (2004) Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope 114(4):738–742. doi:10.1097/00005537-200404000-00027
Khan A, Vaibhav K, Javed H, Tabassum R, Ahmed ME, Khan MM, Islam F (2014) 1,8-cineole (eucalyptol) mitigates inflammation in amyloid Beta toxicated PC12 cells: relevance to Alzheimer’s disease. Neurochem Res 39(2):344–352. doi:10.1007/s11064-013-1231-9
Khansari N, Shakiba Y, Mahmoudi M (2009) Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 3(1):73–80
Kim KY, Lee HS, Seol GH (2015) Eucalyptol suppresses matrix metalloproteinase-9 expression through an extracellular signal-regulated kinase-dependent nuclear factor-kappa B pathway to exert anti-inflammatory effects in an acute lung inflammation model. J Pharm Pharmacol 67(8):1066–1074. doi:10.1111/jphp.12407
Kim KY, Seo HJ, Min SS, Park M, Seol GH (2014) The effect of 1,8-cineole inhalation on preoperative anxiety: a randomized clinical trial. Evid Based Complement Alternat Med 2014:820126. doi:10.1155/2014/820126
Lahlou S, Figueiredo AF, Magalhaes PJ, Leal-Cardoso JH (2002) Cardiovascular effects of 1,8-cineole, a terpenoid oxide present in many plant essential oils, in normotensive rats. Can J Physiol Pharmacol 80(12):1125–1131
Lima PR, de Melo TS, Carvalho KM, de Oliveira IB, Arruda BR, de Castro Brito GA, Santos FA (2013) 1,8-cineole (eucalyptol) ameliorates cerulein-induced acute pancreatitis via modulation of cytokines, oxidative stress and NF-kappaB activity in mice. Life Sci 92(24–26):1195–1201. doi:10.1016/j.lfs.2013.05.009
Liu CH, Chang FY (2011) Development and characterization of eucalyptol microemulsions for topic delivery of curcumin. Chem Pharm Bull (Tokyo) 59(2):172–178
Miyazawa M, Shindo M, Shimada T (2001) Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos 29(2):200–205
Moon HK, Kang P, Lee HS, Min SS, Seol GH (2014) Effects of 1,8-cineole on hypertension induced by chronic exposure to nicotine in rats. J Pharm Pharmacol 66(5):688–693. doi:10.1111/jphp.12195
Moss M, Oliver L (2012) Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma. Ther Adv Psychopharmacol 2(3):103–113. doi:10.1177/2045125312436573
Osiecki H (2004) The role of chronic inflammation in cardiovascular disease and its regulation by nutrients. Altern Med Rev 9(1):32–53
Ryan KA, Smith MF Jr, Sanders MK, Ernst PB (2004) Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun 72(4):2123–2130
Ryu S, Park H, Seol GH, Choi IY (2014) 1,8-Cineole ameliorates oxygen-glucose deprivation/reoxygenation-induced ischaemic injury by reducing oxidative stress in rat cortical neuron/glia. J Pharm Pharmacol 66(12):1818–1826. doi:10.1111/jphp.12295
Sadlon AE, Lamson DW (2010) Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices. Altern Med Rev 15(1):33–47
Santos FA, Silva RM, Campos AR, De Araujo RP, Lima Junior RC, Rao VS (2004) 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis. Food Chem Toxicol 42(4):579–584. doi:10.1016/j.fct.2003.11.001
Singh HP, Mittal S, Kaur S, Batish DR, Kohli RK (2009) Characterization and antioxidant activity of essential oils from fresh and decaying leaves of Eucalyptus tereticornis. J Agric Food Chem 57(15):6962–6966. doi:10.1021/jf9012407
Soares MC, Damiani CE, Moreira CM, Stefanon I, Vassallo DV (2005) Eucalyptol, an essential oil, reduces contractile activity in rat cardiac muscle. Braz J Med Biol Res 38(3):453–461. doi:10.1590//S0100-879X2005000300017
Worth H, Dethlefsen U (2012) Patients with asthma benefit from concomitant therapy with cineole: a placebo-controlled, double-blind trial. J Asthma 49(8):849–853. doi:10.3109/02770903.2012.717657
Worth H, Schacher C, Dethlefsen U (2009) Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Respir Res 10:69. doi:10.1186/1465-9921-10-69
Zhao C, Sun J, Fang C, Tang F (2014) 1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice. Inflammation 37(2):566–572. doi:10.1007/s10753-013-9770-4
Zhou JY, Wang XF, Tang FD, Zhou JY, Lu GH, Wang Y, Bian RL (2007) Inhibitory effect of 1,8-cineol (eucalyptol) on Egr-1 expression in lipopolysaccharide-stimulated THP-1 cells. Acta Pharmacol Sin 28(6):908–912. doi:10.1111/j.1745-7254.2007.00555.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Seol, G.H., Kim, K.Y. (2016). Eucalyptol and Its Role in Chronic Diseases. In: Gupta, S., Prasad, S., Aggarwal, B. (eds) Drug Discovery from Mother Nature. Advances in Experimental Medicine and Biology, vol 929. Springer, Cham. https://doi.org/10.1007/978-3-319-41342-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-41342-6_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41341-9
Online ISBN: 978-3-319-41342-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)